| |
| |
|
| Insider
Information: |
Lyle Corinne H |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
146,030 |
|
|
Indirect Shares
|
2,600 |
|
|
| Direct
Value |
$7,544,014 |
|
|
|
Indirect Value
|
$75,499 |
|
|
| Total
Shares |
148,630 |
|
|
| Total
Value |
$7,619,513 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
CVP & Pres., Global Ops |
2010-05-11 |
16,687 |
2010-02-11 |
2,600 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2008-05-28 |
0 |
Premium* |
|
|
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
80,050 |
2013-03-11 |
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2018-05-07 |
43,283 |
2013-03-28 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2023-05-23 |
6,010 |
2019-01-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EW |
Edwards Lifesciences Corp |
CVP, Chief Financial Officer |
• – – |
2005-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
12,966 |
|
- |
|
| EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Operations |
• – – |
2006-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
19,864 |
|
- |
|
| EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
• – – |
2007-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
26,203 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
• – – |
2008-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
29,656 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
964 |
964 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
• – – |
2009-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
28,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,964 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,964 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,964 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,964 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
11,464 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2013-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
58,350 |
58,350 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
9,600 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
80,050 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,187 |
3,187 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2019-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,726 |
4,913 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
4,283 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
808 |
4,158 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,009 |
5,167 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
843 |
6,010 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-06-19 |
4 |
AS |
$88.25 |
$88,250 |
D/D |
(1,000) |
8,600 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-07-01 |
4 |
AS |
$132.63 |
$663,150 |
D/D |
(5,000) |
3,600 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-07-30 |
4 |
AS |
$131.26 |
$196,890 |
D/D |
(1,500) |
2,100 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-08-08 |
4 |
AS |
$48.54 |
$242,700 |
D/D |
(5,000) |
25,555 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-05-05 |
4 |
AS |
$53.98 |
$269,900 |
D/D |
(5,000) |
34,603 |
0 |
- |
|
69 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
